- Home
- SRZN vs ICCM Comparison
SRZN vs ICCM Comparison
Compare SRZN & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- ICCM
- Stock Information
- Founded
- SRZN 2015
- ICCM 2006
- Country
- SRZN United States
- ICCM Israel
- Employees
- SRZN N/A
- ICCM N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- ICCM
- Sector
- SRZN Health Care
- ICCM
- Exchange
- SRZN Nasdaq
- ICCM Nasdaq
- Market Cap
- SRZN 38.1M
- ICCM 45.5M
- IPO Year
- SRZN N/A
- ICCM N/A
- Fundamental
- Price
- SRZN $10.57
- ICCM $1.12
- Analyst Decision
- SRZN
- ICCM Strong Buy
- Analyst Count
- SRZN 0
- ICCM 2
- Target Price
- SRZN N/A
- ICCM $2.70
- AVG Volume (30 Days)
- SRZN 49.1K
- ICCM 646.4K
- Earning Date
- SRZN 11-06-2024
- ICCM 11-26-2024
- Dividend Yield
- SRZN N/A
- ICCM N/A
- EPS Growth
- SRZN N/A
- ICCM N/A
- EPS
- SRZN N/A
- ICCM N/A
- Revenue
- SRZN $10,000,000.00
- ICCM $3,671,000.00
- Revenue This Year
- SRZN N/A
- ICCM $18.61
- Revenue Next Year
- SRZN N/A
- ICCM $54.91
- P/E Ratio
- SRZN N/A
- ICCM N/A
- Revenue Growth
- SRZN N/A
- ICCM 26.02
- 52 Week Low
- SRZN $6.00
- ICCM $0.48
- 52 Week High
- SRZN $16.19
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- SRZN 54.47
- ICCM 75.27
- Support Level
- SRZN $9.50
- ICCM $0.79
- Resistance Level
- SRZN $11.27
- ICCM $1.19
- Average True Range (ATR)
- SRZN 1.10
- ICCM 0.08
- MACD
- SRZN 0.01
- ICCM 0.03
- Stochastic Oscillator
- SRZN 41.36
- ICCM 84.44
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.